HPV vaccination of immunocompromised hosts

It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to na...

Descripción completa

Detalles Bibliográficos
Autores: Garland, Suzanne M., Brotherton, J. M. L., Moscicki, Anna-Barbara, Kaufmann, A. M., Stanley, Margaret, Bhatla, N., Sankaranarayanan, Rengaswamy, Sanjosé Llongueras, Silvia de, Palefsky, Joel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/124030
Acceso en línea:https://hdl.handle.net/2445/124030
Access Level:acceso abierto
Palabra clave:Vacuna del papil·lomavirus
Papillomavirus vaccines
Descripción
Sumario:It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.

Similares en LA Referencia